Page 69 - Read Online

Masiero et al. Mini-invasive Surg 2022;6:4 https://dx.doi.org/10.20517/2574-1225.2021.104 Page 17 of 19

38. Pighi M, Piazza N, Martucci G, et al. Sex-specific determinants of outcomes after transcatheter aortic valve replacement. Circ
Cardiovasc Qual Outcomes 2019;12:e005363. DOI PubMed
39. O'Connor SA, Morice MC, Gilard M, et al. Revisiting sex equality with transcatheter aortic valve replacement outcomes: a
collaborative, patient-level meta-analysis of 11,310 patients. J Am Coll Cardiol 2015;66:221-8. DOI PubMed
40. Kataruka A, Otto CM. Valve durability after transcatheter aortic valve implantation. J Thorac Dis 2018;10:S3629-36. DOI PubMed
PMC
41. Onorati F, D'Errigo P, Barbanti M, et al; OBSERVANT Research Group. Different impact of sex on baseline characteristics and major
periprocedural outcomes of transcatheter and surgical aortic valve interventions: results of the multicenter Italian OBSERVANT
Registry. J Thorac Cardiovasc Surg 2014;147:1529-39. DOI PubMed
42. Chaker Z, Badhwar V, Alqahtani F, et al. Sex differences in the utilization and outcomes of surgical aortic valve replacement for
severe aortic stenosis. J Am Heart Assoc 2017;6:e006370. DOI PubMed PMC
43. Fuchs C, Mascherbauer J, Rosenhek R, et al. Gender differences in clinical presentation and surgical outcome of aortic stenosis. Heart
2010;96:539-45. DOI PubMed
44. Milavetz DL, Hayes SN, Weston SA, Seward JB, Mullany CJ, Roger VL. Sex differences in left ventricular geometry in aortic
stenosis: impact on outcome. Chest 2000;117:1094-9. DOI PubMed
45. Rahimtoola SH. Valvular heart disease/cardiac surgery. J Am Coll Cardiol 2006;47:D37-40. DOI PubMed
46. Tarantini G, Baumgartner H, Frank D, et al. Four-year mortality in women and men after transfemoral transcatheter aortic valve
implantation using the SAPIEN 3. Catheter Cardiovasc Interv 2021;97:876-84. DOI PubMed
47. Chieffo A, Petronio AS, Mehilli J, et al; WIN-TAVI Investigators. Acute and 30-day outcomes in women after TAVR: results from the
WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) real-world registry. JACC Cardiovasc Interv
2016;9:1589-600. DOI PubMed
48. Chieffo A, Petronio AS, Mehilli J, et al; WIN-TAVI Investigators. 1-year clinical outcomes in women after transcatheter aortic valve
replacement: results from the first WIN-TAVI registry. JACC Cardiovasc Interv 2018;11:1-12. DOI PubMed
49. Saad M, Nairooz R, Pothineni NVK, et al. Long-term outcomes with transcatheter aortic valve replacement in women compared with
men: evidence from a meta-analysis. JACC Cardiovasc Interv 2018;11:24-35. DOI PubMed
50. Szerlip M, Gualano S, Holper E, et al. Sex-specific outcomes of transcatheter aortic valve replacement with the SAPIEN 3 valve:
insights from the PARTNER II S3 high-risk and intermediate-risk cohorts. JACC Cardiovasc Interv 2018;11:13-20. DOI PubMed
51. Wang TY, Gracia E, Callahan S, et al. Gender disparities in management and outcomes following transcatheter aortic valve
implantation with newer generation transcatheter valves. Am J Cardiol 2019;123:1489-93. DOI PubMed
52. Leon MB, Smith CR, Mack MJ, et al; PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-
risk patients. N Engl J Med 2016;374:1609-20. DOI PubMed
53. Ruge H, Burri M, Erlebach M, Lange R. Access site related vascular complications with third generation transcatheter heart valve
systems. Catheter Cardiovasc Interv 2021;97:325-32. DOI PubMed
54. Toggweiler S, Gurvitch R, Leipsic J, et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous
procedure. J Am Coll Cardiol 2012;59:113-8. DOI PubMed
55. Di Mario C, Goodwin M, Ristalli F, et al. A prospective registry of intravascular lithotripsy-enabled vascular access for transfemoral
transcatheter aortic valve replacement. JACC Cardiovasc Interv 2019;12:502-4. DOI PubMed
56. Dencker D, Taudorf M, Luk NH, et al. Frequency and effect of access-related vascular injury and subsequent vascular intervention
after transcatheter aortic valve replacement. Am J Cardiol 2016;118:1244-50. DOI PubMed
57. Witberg G, Tzalamouras V, Adams H, et al. Routine ultrasound or fluoroscopy use and risk of vascular/bleeding complications after
transfemoral TAVR. JACC Cardiovasc Interv 2020;13:1460-8. DOI PubMed
58. Power D, Schäfer U, Guedeney P, et al. Impact of percutaneous closure device type on vascular and bleeding complications after
TAVR: a post hoc analysis from the BRAVO-3 randomized trial. Catheter Cardiovasc Interv 2019;93:1374-81. DOI PubMed
59. Buchanan GL, Chieffo A, Montorfano M, et al. A “modified crossover technique” for vascular access management in high-risk
patients undergoing transfemoral transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2013;81:579-83. DOI PubMed
60. Claessen BE, Tang GHL, Kini AS, Sharma SK. Considerations for optimal device selection in transcatheter aortic valve replacement: a
review. JAMA Cardiol 2021;6:102-12. DOI PubMed
61. Lee M, Modine T, Piazza N, Mylotte D. TAVI device selection: time for a patient-specific approach. EuroIntervention 2016;12:Y37-
41. DOI PubMed
62. Fischer Q, Urena M, Bouleti C, et al. Performing optimal transcatheter aortic valve implantation: the need for tailored use of
transcatheter valves. Arch Cardiovasc Dis 2019;112:512-22. DOI PubMed
63. Renker M, Kim WK. Choice of transcatheter heart valve: should we select the device according to each patient's characteristics or
should it be “one valve fits all”? Ann Transl Med 2020;8:961. DOI PubMed PMC
64. Faquir N, Ren B, Van Mieghem NM, Bosmans J, de Jaegere PP. Patient-specific computer modelling - its role in the planning of
transcatheter aortic valve implantation. Neth Heart J 2017;25:100-5. DOI PubMed PMC
65. Abdelghani M, Mankerious N, Allali A, et al. Bioprosthetic valve performance after transcatheter aortic valve replacement with self-
expanding versus balloon-expandable valves in large versus small aortic valve annuli: insights from the CHOICE trial and the
CHOICE-extend registry. JACC Cardiovasc Interv 2018;11:2507-18. DOI PubMed
66. Hase H, Yoshijima N, Yanagisawa R, et al; OCEAN-TAVI Investigators. Transcatheter aortic valve replacement with Evolut R versus
Sapien 3 in Japanese patients with a small aortic annulus: the OCEAN-TAVI registry. Catheter Cardiovasc Interv 2021;97:E875-86.
DOI PubMed